Morepen Laboratories Limited’ Q3 FY24 EBITDA Surges by 151 per cent, Net Profit Records a Remarkable 256 per Growth
Mumbai (Maharashtra) [India], February 5: Morepen Laboratories Limited (NSE: MOREPENLAB, BSE: 500288), is engaged in the business of manufacturing, producing, developing and marketing a wide range of Active Pharmaceutical Ingredients (APIs), branded and generic formulations and also the Home Health products. The Company reported its unaudited Q3FY24 financial results. Key Financial Highlights (Consolidated): Consolidated Key Financial Highlights Q3 FY24: […]
Continue Reading